9.200
−2,13%
2026-10-19
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -89.3% | +5.3% | 1 / 3 | +4.8% | -10.12 pp | -18.30 pp | +7.1% | 0.29 | 9.81 | 74,3 | +4,8% | 2,3 | −84,8% | 9.81 | 7.28 | +34,8% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 9.200 (close price on 2026-10-19)EPS (TTM): 937,4
Financial charts
1.Revenue & growth
VND bn74,3Q2/26
1.Revenue & growth
VND bn74,3Q2/26
2.Profit & growth
VND bn1,57Q2/26
3.Profit mix (Penman)
VND bn29,9Q2/26
4.Margins & cost structure
%36.4%Q2/26
5.Returns & cash cycle
% · days5.4%Q2/26
6.Earnings quality & cash
VND bn18,3Q2/26
7.Asset structure
VND bn542Q2/26
8.Funding & debt health
VND bn · times542Q2/26
9.Revenue backlog
VND bn2,63Q2/26
10.Valuation
times · %10,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %52Q2/26
Adjusted EPS growth, latest quarter
-89.3%
Average adjusted EPS growth, 3 quarters
5.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26